UA12/9 March Newsletter

Newsletter produced and distributed by the WKU Counseling & Testing Center

UA12/9 WKU Counseling & Testing Center, Vol. 5, Issue 4

Newsletter created by and about the WKU Counseling & Testing Center

implications for diagnosis and treatment

Inappropriately high breakpoints have resulted in systematic false-susceptible AST results to anti-TB drugs. MIC, PK/PD and clinical outcome data should be combined when setting breakpoints to minimise the emergence and spread of antimicrobial resistance. https://bit.ly/3i43wb6publishersversionpublishe

Professional accounting testing program

https://egrove.olemiss.edu/aicpa_comm/1224/thumbnail.jp

College accounting testing program bulletin no. 46; Results, Fall 1962

https://egrove.olemiss.edu/aicpa_comm/1464/thumbnail.jp

Mine Action 2020: Book of Papers

Book of papers that was to be presented at the 2020 Mine Action Symposium in Croatia. The Symposium canceled due to COVID-19

Proficiency Testing of Viral Marker Screening in African Blood Centers - Seven African Countries, 2017.

A 2014 report evaluating accuracy of serologic testing for transfusion-transmissible viruses at African blood center laboratories found sensitivities of 92%, 87%, and 90% for detecting infections with human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV), respectively (1). Following substantial investments in national blood transfusion service (NBTS) laboratories, in 2017 investigators tested proficiency at 84 blood center laboratories (29 NBTS and 55 non-NBTS) in seven African countries. A blinded panel of 25 plasma samples was shipped to each participating laboratory for testing with their usual protocols based on rapid diagnostic tests (RDTs) (2) and third and fourth generation enzyme immunoassays (EIA-3 and EIA-4). Sensitivity and specificity were estimated using separate regression models that clustered assays by laboratory and adjusted for assay type and NBTS laboratory status. Mean specificities were ≥95% for all three viruses; however, mean sensitivities were 97% for HIV-positive, 76% for HBV-positive, and 80% for HCV-positive samples. Testing sensitivities for all viruses were high when EIA-3 assays were used (≥97%). Lower sensitivities for HBV-positive samples and HCV-positive samples were associated with assay types other than EIA-3, used primarily by non-NBTS laboratories. Proficiency for HIV testing has improved following international investments, but proficiency remains suboptimal for HBV and HCV testing. In sub-Saharan African blood centers, the quality of rapid tests used for HBV and HCV screening needs to be improved or their use discouraged in favor of EIA-3 tests

College accounting testing program bulletin no. 48; Results, Spring 1963

https://egrove.olemiss.edu/aicpa_comm/1466/thumbnail.jp